Stocks with the largest after-hours movements: Hims & Hers, Gitlab, Cleanspark, Webtoon Entertainment, and others.
Market Reactions and Company Updates After the market closed, several companies experienced notable fluctuations in their stock prices: Hims & Hers Health — The telehealth provider’s shares fell over 6%. The company projected an adjusted EBITDA for the ongoing quarter between $35 million and $55 million, which was much lower than the $70 million analysts […]
Midday stock movements: Intel, AMD, Charter, Hims & Hers, Eli Lilly and others
Here’s a look at companies making notable moves in intraday trading: Comcast, the parent company of NBCUniversal, saw its stock drop almost 8%. This came after Deutsche Bank changed its rating from buy to hold, expressing concerns over sustainable earnings and cash flow growth. Charter Communications experienced a significant decline as well, falling 23% after […]
Hims Stock Achieves Record Week as Novo Agreement Boosts Confidence
Hims & Hers Health Stock Surges After Novo Nordisk Partnership (Bloomberg) — Shares of Hims & Hers Health saw an impressive rise this week, hitting their highest level ever after the company announced a partnership with Novo Nordisk A/S, bringing fresh optimism regarding its future in weight-loss medications. The San Francisco-based firm experienced a 57% […]
Hims & Hers launches blood test for 50 different cancers
New Blood Test Detects Cancer Before Symptoms Appear Waiting for cancer symptoms to emerge may soon be a thing of the past. This week, the telemedicine service Hims & Hers launched a blood test that screens for multiple types of cancer, even those without standard checkups. “Catching cancer early usually provides more treatment options and […]
Stocks with the largest changes in after-hours trading: Palantir, Hims & Hers Health, Clorox, and others
After-Hours Trading Highlights Let’s dive into some companies making headlines in after-hours trading. Palantir Technologies saw a 1% increase in its stock after it reported quarterly results that surpassed Wall Street forecasts, with government revenue jumping 52% compared to a year earlier. The company posted adjusted earnings of 21 cents per share on sales of […]
Hims & Hers Health’s Q3 Sales Exceed Expectations
Hims & Hers Health Reports Q3 2025 Results Telemedicine firm Hims & Hers Health (NYSE:HIMS) has unveiled its third-quarter results for 2025, showcasing a revenue increase of 49.2% year-over-year, totaling $599 million. However, its revenue forecast for the upcoming quarter, set at $615 million, fell 2.6% short of analyst predictions. Also, the company reported GAAP […]
Before Q3 Earnings, Let’s Examine the Owners of Hims & Hers Health Stock (HIMS)
Him’s & Hers Health Financial Update Him’s & Hers Health (HIMS), a telemedicine platform, is set to release its third quarter financial results on Monday, November 3rd, after the market closes. Recently, the stock has dipped by 22% over the last month, mainly due to insider selling, but it’s still holding on with a year-to-date […]
Midday stock movements: Webtoon Entertainment, Steel Dynamics, Hims & Hers and others
Market Update: Key Moves in Various Companies In recent trading news, Webtoon Entertainment’s stock surged by 31% following an agreement to develop a digital comics platform for Disney. Additionally, they will be selling a 2% stake to the media giant. On the flip side, Emerson Electric saw its shares drop by 4.5%. The company’s management […]
Hims Stock Increases as FDA Releases “Green List,” Novo Nordisk Shares Decrease
Shares of HIMS & HERS (HIMS) increased by 2.6% on Monday following the FDA’s release of a “green list” of global suppliers offering ingredients that meet GLP-1 standards. This announcement indicates that the company will begin to take on compound interest, allowing them to gather active ingredients and create customized versions of GLP-1 weight loss […]
Defiance ETFs Introduces Leveraged and Income ETFs for Palantir, Hims & Hers Health, and Robinhood Markets
Defiance ETFs has introduced three new leveraged ETFs focused on individual stocks: Palantir Technologies, Hims & Hers Health, and Robinhood Markets. These funds aim to combine leveraged exposure with revenue strategies. On August 19, 2025, it was announced that Defiance is a pioneer in innovative exchange-traded products. The newly launched Leveraged Long + Income ETFs […]